PURPOSE: To determine the frequency and types of dental abnormalities among children treated at a young age for cancer, as represented by neuroblastoma. PATIENTS AND METHODS: We retrospectively reviewed the dental records and panoramic radiographs of 542 children who were treated for neuroblastoma at our institution over a 31-year period. Patients in our study had to meet the following criteria: they were treated on an institutional protocol, they had undergone panoramic radiography, and their dental follow-up continued for at least 2 years after diagnosis. We evaluated the frequency of clinically or radiographically apparent microdontia, excessive caries, root stunting, hypodontia, and enamel hypoplasia in our study population. RESULTS: Of the 52 patients who met the study criteria, 71% developed dental abnormalities, comprising microdontia in 38%, excessive caries in 29%, root stunting in 17%, hypodontia in 17%, and enamel hypoplasia in 17%. In nearly half (23) of our patients, neuroblastoma was diagnosed on or before their first birthday. CONCLUSION: Children treated for neuroblastoma are at high risk for abnormal dental development. The abnormalities in these patients may require extensive dental care and can compromise their quality of life. Frequent dental examinations and an intense oral hygiene program before, during, and after treatment may improve overall dental health.
PURPOSE: To determine the frequency and types of dental abnormalities among children treated at a young age for cancer, as represented by neuroblastoma. PATIENTS AND METHODS: We retrospectively reviewed the dental records and panoramic radiographs of 542 children who were treated for neuroblastoma at our institution over a 31-year period. Patients in our study had to meet the following criteria: they were treated on an institutional protocol, they had undergone panoramic radiography, and their dental follow-up continued for at least 2 years after diagnosis. We evaluated the frequency of clinically or radiographically apparent microdontia, excessive caries, root stunting, hypodontia, and enamel hypoplasia in our study population. RESULTS: Of the 52 patients who met the study criteria, 71% developed dental abnormalities, comprising microdontia in 38%, excessive caries in 29%, root stunting in 17%, hypodontia in 17%, and enamel hypoplasia in 17%. In nearly half (23) of our patients, neuroblastoma was diagnosed on or before their first birthday. CONCLUSION:Children treated for neuroblastoma are at high risk for abnormal dental development. The abnormalities in these patients may require extensive dental care and can compromise their quality of life. Frequent dental examinations and an intense oral hygiene program before, during, and after treatment may improve overall dental health.
Authors: Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Louis S Constine; Leslie L Robison; Kirsten K Ness Journal: Pediatr Blood Cancer Date: 2013-11-01 Impact factor: 3.167
Authors: Karen E Effinger; Cesar A Migliorati; Melissa M Hudson; Kevin P McMullen; Sue C Kaste; Kathy Ruble; Gregory M T Guilcher; Ami J Shah; Sharon M Castellino Journal: Support Care Cancer Date: 2014-04-30 Impact factor: 3.603
Authors: Sue C Kaste; Pamela Goodman; Wendy Leisenring; Marilyn Stovall; Robert J Hayashi; Mark Yeazel; Soraya Beiraghi; Melissa M Hudson; Charles A Sklar; Leslie L Robison; K Scott Baker Journal: Cancer Date: 2009-12-15 Impact factor: 6.860
Authors: Catherine H L Hong; Joel J Napeñas; Brian D Hodgson; Monique A Stokman; Vickie Mathers-Stauffer; Linda S Elting; Fred K L Spijkervet; Michael T Brennan Journal: Support Care Cancer Date: 2010-05-07 Impact factor: 3.603
Authors: Adepitan A Owosho; Paul Brady; Suzanne L Wolden; Leonard H Wexler; Cristina R Antonescu; Joseph M Huryn; Cherry L Estilo Journal: Pediatr Hematol Oncol Date: 2016-09-30 Impact factor: 1.969
Authors: Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Annu Singh; Shakeel Modak; Armand K Solano; Brian H Kushner; Suzanne Wolden; Joseph Huryn; Cherry L Estilo Journal: Pediatr Blood Cancer Date: 2021-01-28 Impact factor: 3.167